CTOs on the Move

Pharvaris

www.pharvaris.com

 
Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients. By targeting this clinically proven therapeutic target with novel small molecules, the Pharvaris team is advancing new alternatives to injected therapies for all sub-types of HAE and other bradykinin-mediated diseases. The company brings together executives with a breadth of expertise across pharmaceutical development and rare disorders, including HAE. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.pharvaris.com
  • 1 Cranberry Hill Suite 300
    Lexington, MA USA 02421
  • Phone: 212.845.4262

Executives

Name Title Contact Details
Stefan Abele
Chief Technical Operations Officer Profile

Similar Companies

Impel Pharmaceuticals

Impel Pharmaceuticals specializes in Precision Olfactory Delivery (POD) nasal devices for Alzheimers, migraine, and other central nervous system diseases.

NxStage Medical

NxStage System One dialysis machines offer the comfort and flexibility of hemodialysis at home. Discover how our products can improve your quality of life.

Cassini Technologies

Driven by curiosity and love of science Cassini has been dedicated to push the boundaries of corneal diagnostics solutions ✓ Advised by top surgeons

Epic Care

We are a dynamic organization committed to providing compassionate, high-quality healthcare across the Northern California East Bay.

Fulcrum Pharma Developments

Fulcrum Pharma Developments Inc. is a Morrisville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.